You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Sun Pharmaceuticals Industries Ltd"

Sun Pharmaceuticals Industries Ltd Closure of Trading Window

  • 23/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 22/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 18/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 15/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 11/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 07/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 04/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 03/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript

  • 02/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 02/06/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 29/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Acquisition Of Trademarks And Patent License For Dapagliflozin And Its Combinations From Astrazeneca

  • 28/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 27/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Corporate Action-Board approves Dividend

  • 27/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd 1) Approval Of Audited Standalone And Consolidated Financial Statements For The Quarter And Year End

  • 27/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Result - Audited Financial Results For The Quarter And Year Ended March 31 2021 Recommended Final Di

  • 27/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 27/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 26/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 20/05/2021
  • |
  • bse

Sun Pharmaceuticals Industries Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 18/05/2021
  • |
  • bse